Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quantum Genesis AIQGAI +96.49% Peter Lynch Fair Value is $-0.14 as of Sep. 22, 2026. The stock has 2 warning signs investors should review. Among 407 Chemicals companies, Quantum Genesis AI ranks worse than 245700% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Quantum Genesis AI's PEG is 1. Quantum Genesis AI's 5-Year TTM EBITDA Growth Rate is 25.
Quantum Genesis AI's EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.01. Therefore, the Peter Lynch Fair Value for today is $-0.14.
The historical rank and industry rank for Quantum Genesis AI's Peter Lynch Fair Value or its related term are showing as below:
QGAI's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Chemicals industry.
Industry Median: 1.32 * Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Quantum Genesis AI (OTCPK:QGAI) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 25 instead of 15 in this case.
Quantum Genesis AI's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
0.1399
/
-0.14
=
N/A
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quantum Genesis AI Peter Lynch Fair Value Related Terms
Quantum Genesis AI Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for Quantum Genesis AI's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QGAI vs BGLC, CNEY, TSEOQ: Peter Lynch Fair Value Comparison
For the Specialty Chemicals subindustry, Quantum Genesis AI's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quantum Genesis AI Price-to-Peter-Lynch-Fair-Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Quantum Genesis AI's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Quantum Genesis AI's Price-to-Peter-Lynch-Fair-Value falls into.
Quantum Genesis AI's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-0.01.
* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
What does a Peter Lynch Fair Value of $-0.14 mean?
Quantum Genesis AI (QGAI) has a Peter Lynch Fair Value of $-0.14 as of Sep. 22, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Quantum Genesis AI and its competitors. According to the industry distribution chart, Quantum Genesis AI ranks #999999 out of 407 companies in the Chemicals industry.
Is Quantum Genesis AI's Peter Lynch Fair Value too high?
Quantum Genesis AI's current Peter Lynch Fair Value is $-0.14. Based on the distribution chart, Quantum Genesis AI ranks #999999 out of 407 companies in the Chemicals industry, which is in the bottom quartile relative to peers.
How does Quantum Genesis AI's Peter Lynch Fair Value compare to BGLC and CNEY?
According to the Chemicals industry distribution chart, Quantum Genesis AI ranks #999999 out of 407 companies for Peter Lynch Fair Value. This places Quantum Genesis AI in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.32. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Chemicals company?
The median Peter Lynch Fair Value among Chemicals companies is 1.32, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Quantum Genesis AI and its competitors. For the Chemicals industry, the median Peter Lynch Fair Value is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quantum Genesis AI's current Peter Lynch Fair Value is $-0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum Genesis AI stock overvalued right now?
Quantum Genesis AI (QGAI) has a current Peter Lynch Fair Value of $-0.14. The current Peter Lynch Fair Value is $-0.14. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Quantum Genesis AI (QGAI), the current Peter Lynch Fair Value is $-0.14 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quantum Genesis AI Corp, formerly Quantumzyme Corp, is a US-based company focused on biotransformation and clean chemistry solutions. It develops enzyme-based technologies intended to replace conventional chemical processes with more sustainable alternatives. The company applies quantum mechanics, molecular modeling, and engineering approaches to enhance enzyme activity, selectivity, and specificity, with research guided by customer needs. Its solutions target industrial applications where biocatalysis can improve efficiency and reduce environmental impact, serving customers in sectors such as specialty chemicals, pharmaceuticals, and industrial manufacturing. Revenue is generated through research collaborations, technology development agreements, and licensing or service arrangements with corporate partners. The company operates primarily from the United States, with a business model centered on partnering with industry to develop and deploy tailored enzymatic processes rather than large-scale commodity manufacturing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QGAI has been successfully added to your 
